Senait Aschenafi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
CONTEXT Minimal residual disease (MRD) in patients treated for hairy cell (HC) leukemia as assessed by immunohistochemistry has not been included routinely in evaluation of treatment results. OBJECTIVE To assess the presence of persistent HCs after treatment, as detected by immunohistochemistry, and to evaluate the correlation between the level of MRD and(More)
  • 1